ACT-1004-1239 is an orally active, selective, and potent CXCR7 antagonist with immune-modulatory and myelin-promoting effects. It can be used to study inflammatory demyelinating diseases.
Molecular Weight:
522.55
Purity:
98.31%
CAS Number:
[2178049-58-4]
Formula:
C27H28F2N6O3
Target:
CXCR
T39665
* VAT and and shipping costs not included. Errors and price changes excepted